1060802-18-7 Usage
Description
5-Chloro-3-pyridinesulfonyl chloride is an organic compound with the chemical formula C5H3ClNOS2Cl. It is a derivative of pyridine, a heterocyclic aromatic compound, and features a chloro and sulfonyl chloride functional groups attached to the pyridine ring. 5-chloropyridine-3-sulfonyl chloride is known for its reactivity and is commonly used in the synthesis of various pharmaceuticals and organic compounds.
Uses
Used in Pharmaceutical Industry:
5-Chloro-3-pyridinesulfonyl chloride is used as a key intermediate in the synthesis of proton pump inhibitors, specifically tetrahydrocyclopentapyrroles. These inhibitors are essential in the development of medications that treat conditions such as acid reflux, gastroesophageal reflux disease (GERD), and peptic ulcers. 5-chloropyridine-3-sulfonyl chloride plays a crucial role in the formation of the active pharmaceutical ingredients (APIs) that help regulate the production of stomach acid, providing relief and treatment for the aforementioned conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1060802-18-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,0,8,0 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1060802-18:
(9*1)+(8*0)+(7*6)+(6*0)+(5*8)+(4*0)+(3*2)+(2*1)+(1*8)=107
107 % 10 = 7
So 1060802-18-7 is a valid CAS Registry Number.
1060802-18-7Relevant articles and documents
ACLY INHIBITORS AND USES THEREOF
-
Paragraph 00833, (2020/06/01)
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
SULFONYL PYRIDYL TRP INHIBITORS
-
Paragraph 0252-0253, (2018/03/06)
The invention is concerned with the compounds of formula I: (I) and pharmaceutically acceptable salts thereof where R1 is a substituted or unsubstituted phenyl or a fused bicyclic comprising a substituted or unsubstituted phenyl. In addition, t
PYRROLE COMPOUNDS
-
Page/Page column 73, (2010/04/06)
The present invention relates to a compound represented by the formula: wherein A is pyridyl group having at least one substituent wherein R1, R2 and R3 are each a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally substituted by halogen or a C1-6 alkoxy group optionally substituted by halogen, R4 and R6 are each a hydrogen atom, a halogen atom or a C1-6 alkyl group optionally substituted by halogen, R5 is a hydrogen atom, a halogen atom, a C1-6 alkyl group optionally substituted by halogen or a C1-6 alkoxy group optionally substituted by halogen, and R7 is a hydrogen atom or a C1-6 alkyl group optionally substituted by halogen or a salt thereof, or a pharmaceutical composition containing the same.
